SCHEMBL8080995

SCHEMBL8080995

CSC1=NC(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.33
GPR119 Q8TDV5 1/20 0.32
HRH3 Q9Y5N1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8080990 1.00 MAPK1 (0.33) MAPK1GPR119HRH3
SCHEMBL8329381 0.77 NOS3 (0.38) MAPK1HRH3
SCHEMBL5902243 0.75
SCHEMBL30114557 0.75 MAPK1 (0.33) MAPK1HRH3
Hydrochloric Acid SCHEMBL7446749 0.75 NOS3 (0.40) MAPK1HRH3
SCHEMBL1903969 0.67 MAPK1 (0.36) MAPK1GPR119HRH3
SCHEMBL23182892 0.66 KDM4E (0.35)
SCHEMBL17646713 0.66 KDM4E (0.35)
SCHEMBL1901073 0.63 GAA (0.35) MAPK1HRH3
SCHEMBL4200760 0.63 GAA (0.35) MAPK1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1037905-A1 ANTIPICORNAVIRAL COMPOUNDS AND METHODS FOR THEIR USE AND PREPARATION AGOURON PHARMACEUTICALS, INC. (US) 2000-09-27 EP disclosed
US-5962487-A PICORNAVIRAL 3C PROTEASE INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 1999-10-05 US disclosed
WO-1999031122-A9 ANTIPICORNAVIRAL COMPOUNDS AND METHODS FOR THEIR USE AND PREPARATION AGOURON PHARMA (US) 1999-09-30 WO disclosed
WO-1999031122-A1 ANTIPICORNAVIRAL COMPOUNDS AND METHODS FOR THEIR USE AND PREPARATION AGOURON PHARMACEUTICALS, INC. (US) 1999-06-24 WO disclosed